Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear

Matthias F.J. Sperl (Corresponding author), Christian Panitz, Nadine Skoluda, Urs M. Nater, Diego A. Pizzagalli, Christiane Hermann, Erik M. Mueller

Publications: Contribution to journalArticlePeer Reviewed

Abstract

BACKGROUND: Hyperconsolidation of aversive associations and poor extinction learning have been hypothesized to be crucial in the acquisition of pathological fear. Previous animal and human research points to the potential role of the catecholaminergic system, particularly noradrenaline and dopamine, in acquiring emotional memories. Here, we investigated in a between-participants design with 3 groups whether the noradrenergic alpha-2 adrenoreceptor antagonist yohimbine and the dopaminergic D2-receptor antagonist sulpiride modulate long-term fear conditioning and extinction in humans. METHODS: Fifty-five healthy male students were recruited. The final sample consisted of n = 51 participants who were explicitly aware of the contingencies between conditioned stimuli (CS) and unconditioned stimuli after fear acquisition. The participants were then randomly assigned to 1 of the 3 groups and received either yohimbine (10 mg, n = 17), sulpiride (200 mg, n = 16), or placebo (n = 18) between fear acquisition and extinction. Recall of conditioned (non-extinguished CS+ vs CS-) and extinguished fear (extinguished CS+ vs CS-) was assessed 1 day later, and a 64-channel electroencephalogram was recorded. RESULTS: The yohimbine group showed increased salivary alpha-amylase activity, confirming a successful manipulation of central noradrenergic release. Elevated fear-conditioned bradycardia and larger differential amplitudes of the N170 and late positive potential components in the event-related brain potential indicated that yohimbine treatment (compared with a placebo and sulpiride) enhanced fear recall during day 2. CONCLUSIONS: These results suggest that yohimbine potentiates cardiac and central electrophysiological signatures of fear memory consolidation. They thereby elucidate the key role of noradrenaline in strengthening the consolidation of conditioned fear associations, which may be a key mechanism in the etiology of fear-related disorders.

Original languageEnglish
Pages (from-to)759–773
Number of pages15
JournalInternational Journal of Neuropsychopharmacology
Volume25
Issue number9
Early online date24 Jun 2022
DOIs
Publication statusPublished - Sept 2022

Austrian Fields of Science 2012

  • 501010 Clinical psychology

Keywords

  • Fear conditioning
  • norepinephrine
  • dopamine
  • yohimbine
  • sulpiride
  • EVENT-RELATED POTENTIALS
  • NORADRENERGIC MODULATION
  • FACILITATES EXTINCTION
  • INTRUSIVE MEMORIES
  • EXTINGUISHED FEAR
  • INDUCED INCREASES
  • STRESS-DISORDER
  • FRONTAL-CORTEX
  • DOPAMINE
  • SYSTEM
  • POSTTRAUMATIC-STRESS-DISORDER
  • SEX-DIFFERENCES

Fingerprint

Dive into the research topics of 'Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear'. Together they form a unique fingerprint.

Cite this